WASHINGTON, Jan. 12 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I.

The rule was published in the Federal Register on Jan. 12 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H-benzimidazole (other names: N-pyrrolidino metonitazene or metonitazepyne) and 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 H-benzimidazole (other names: N-pyrrolidino protonitazene or protonitazep...